These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31969155)

  • 1. Vivax malaria in pregnancy and lactation: a long way to health equity.
    Brummaier T; Gilder ME; Gornsawun G; Chu CS; Bancone G; Pimanpanarak M; Chotivanich K; Nosten F; McGready R
    Malar J; 2020 Jan; 19(1):40. PubMed ID: 31969155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
    Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
    PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
    PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical cure for Plasmodium vivax malaria after G6PD qualitative testing in four provinces in Cambodia, results from Phase I implementation.
    Lek D; Tsai YC; Hirano J; Sovannaroth S; Bunreth V; Vonn P; Vannthen O; Bunkea T; Samphornarann T; Sokomar N; Sarath M; Kheang ST; Wong E; Burbach MK; Hughes J; Rekol H
    Malar J; 2024 Feb; 23(1):56. PubMed ID: 38395925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
    Brito-Sousa JD; Murta F; Vitor-Silva S; Sampaio VS; Mendes MO; Brito MAM; Batista TSB; Santos APC; Marques LLG; Barbosa LRA; Melo MM; Baia-da-Silva DC; Silva-Neto AV; Santos TC; Souza BKA; Figueiredo EFG; Silva EL; Rodovalho S; Nakagawa TH; Arcanjo AR; Siqueira AM; Melo GC; Recht J; Domingo GJ; Bassat Q; Bancone G; Monteiro WM; Lacerda MVG
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009415. PubMed ID: 34003840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
    Brito M; Rufatto R; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Menezes A; Ataídes R; Batista Pereira D; Lacerda M
    Lancet Glob Health; 2024 Mar; 12(3):e467-e477. PubMed ID: 38365417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
    Brito M; Rufatto R; Brito-Sousa JD; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Batista Pereira D; Lacerda M
    Lancet Infect Dis; 2024 Jun; 24(6):629-638. PubMed ID: 38452779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
    Kheang ST; Ridley R; Ngeth E; Ir P; Ngor P; Sovannaroth S; Lek D; Phon S; Kak N; Yeung S
    PLoS One; 2022; 17(10):e0275822. PubMed ID: 36264996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of G6PD testing and primaquine for
    Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
    WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
    Thriemer K; Poespoprodjo JR; Kenangalem E; Douglas NM; Sugiarto P; Anstey NM; Simpson JA; Price RN
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008838. PubMed ID: 33175835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
    Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
    PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
    Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
    Baird JK; Battle KE; Howes RE
    Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
    Lo E; Zhong D; Raya B; Pestana K; Koepfli C; Lee MC; Yewhalaw D; Yan G
    Malar J; 2019 Oct; 18(1):340. PubMed ID: 31590661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of glucose-6-phosphate dehydrogenase (G6PD) activity during Plasmodium vivax infection: implications for early radical malaria treatment.
    Dahuron L; Goungounga J; Drame M; Douine M; Nacher M; Blaise T; Mosnier E; Musset L; Fouillet M; Djossou F; Epelboin L
    Malar J; 2024 May; 23(1):140. PubMed ID: 38725027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
    Rajasekhar M; Simpson JA; Ley B; Edler P; Chu CS; Abreha T; Awab GR; Baird JK; Bancone G; Barber BE; Grigg MJ; Hwang J; Karunajeewa H; Lacerda MVG; Ladeia-Andrade S; Llanos-Cuentas A; Pukrittayakamee S; Rijal KR; Saravu K; Sutanto I; Taylor WRJ; Thriemer K; Watson JA; Guerin PJ; White NJ; Price RN; Commons RJ;
    Lancet Infect Dis; 2024 Feb; 24(2):184-195. PubMed ID: 37748497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
    IMPROV Study Group
    BMC Infect Dis; 2015 Dec; 15():558. PubMed ID: 26643116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.